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Abstract: Leptin receptor (LepR) signaling in neurons of the ventromedial nucleus of the hypothalamus
(VMH), specifically those expressing steroidogenic factor-1 (SF1), have been proposed to play a key role
in controlling energy balance. By crossing LepR-silenced (LepR) mice to those expressing SF1-Cre, we
unsilenced native LepR specifically in the VMH and tested whether SF1 neurons in the VMH are critical
mediators of leptin’s effect on energy homeostasis. LepR x SF1-Cre (KO/Tg+) mice were metabolically
phenotyped and compared to littermate controls that either expressed or were deficient in LepR. Leptin-
induced pSTAT3 was present in the VMH of KO/Tg+ mice and absent in other hypothalamic nuclei.
VMH leptin signaling did not ameliorate obesity resulting from LepR-deficiency in chow-fed mice. There
was no change in food intake or energy expenditure when comparing complete LepR-null mice to KO/Tg+
mice, nor did KO/Tg+ show improved glucose tolerance. The presence of functional LepR in the VMH
mildly enhanced sensitivity to the pancreatic hormone amylin. When maintained on high fat diet (HFD),
there was no reduction in diet-induced obesity in KO/Tg+ mice, but KO/Tg+ mice had improved glucose
tolerance after 7 weeks on HFD compared to LepR-null mice. We conclude that LepR signaling in the
VMH alone is not sufficient to correct metabolic dysfunction observed in LepR-null mice.
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ABSTRACT 41 
Leptin receptor (LepR) signaling in neurons of the ventromedial nucleus of 42 
the hypothalamus (VMH), specifically those expressing steroidogenic factor-1 43 
(SF1), have been proposed to play a key role in controlling energy balance. 44 
By crossing LepR-silenced (LepRloxTB) mice to those expressing SF1-Cre, we 45 
unsilenced native LepR specifically in the VMH and tested whether SF1 46 
neurons in the VMH are critical mediators of leptin’s effect on energy 47 
homeostasis. LepRloxTB x SF1-Cre (KO/Tg+) mice were metabolically 48 
phenotyped and compared to littermate controls that either expressed or were 49 
deficient in LepR. Leptin-induced pSTAT3 was present in the VMH of KO/Tg+ 50 
mice and absent in other hypothalamic nuclei. VMH leptin signaling did not 51 
ameliorate obesity resulting from LepR-deficiency in chow-fed mice. There 52 
was no change in food intake or energy expenditure when comparing 53 
complete LepR-null mice to KO/Tg+ mice, nor did KO/Tg+ show improved 54 
glucose tolerance. The presence of functional LepR in the VMH mildly 55 
enhanced sensitivity to the pancreatic hormone amylin. When maintained on 56 
high fat diet (HFD), there was no reduction in diet-induced obesity in KO/Tg+ 57 
mice, but KO/Tg+ mice had improved glucose tolerance after 7 weeks on 58 
HFD compared to LepR-null mice. We conclude that LepR signaling in the 59 
VMH alone is not sufficient to correct metabolic dysfunction observed in 60 
LepR-null mice.  61 
  62 
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INTRODUCTION 63 
Leptin, a hormone mainly produced and secreted by the adipocytes of the 64 
white adipose tissue, acts in the brain to directly control body weight, food 65 
intake, and energy expenditure. Obesity in mice due to a deficiency of leptin 66 
(ob/ob) or its receptor (db/db) occurs together with hyperphagia, diabetes and 67 
aberrant metabolic homeostasis (20, 27, 33). Leptin exerts its actions by 68 
activating the b isoform of the leptin receptor (LepR), which is expressed in 69 
various brain regions involved in the control of energy homeostasis, including 70 
the arcuate nucleus (ARH) and the ventromedial nucleus of the hypothalamus 71 
(VMH) (9, 13, 16).  72 
 73 
Leptin activates VMH neurons as demonstrated by their expression of 74 
phosphorylated STAT3 (pSTAT3), a marker of leptin signaling (9). 75 
Furthermore, many genes expressed in the VMH are involved in the control of 76 
energy homeostasis, notably steroidogenic factor-1 (SF1) (8, 21). SF1 is 77 
exclusively expressed in a subpopulation of VMH neurons, and is crucial for 78 
the correct development of the VMH and the formation of its efferent and 79 
afferent circuits (6, 7, 28). SF1 is also required for the expression of LepR 80 
and leptin-responsiveness in the VMH (8, 21). In rodents, deletion of LepR in 81 
SF1 neurons leads to heightened sensitivity to high fat diet, impaired glucose 82 
tolerance and increased levels of insulin and leptin (3, 9), suggesting that 83 
these neurons are protective against diet-induced obesity (DIO) and mediate 84 
leptin’s glucoregulatory effects. The VMH is also the proposed brain site 85 
where leptin and the pancreatic hormone amylin interact to produce a 86 
synergistic reduction in body weight and food intake (19, 23). We recently 87 
observed reduced amylin sensitivity in LepR-deficeint db/db mice (11), 88 
leading to the hypothesis that reactivation of a single LepR population, such 89 
as VMH neurons, might restore amylin sensitivity.  90 
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 91 
While the requirement for native LepR in SF1 neurons in the VMH has been 92 
previously demonstrated (3, 9), their sufficiency has not. An earlier study, 93 
which overexpressed LepR in all SF1-positive cells of db/db mice, provided 94 
some indication of the sufficiency of LepR in the VMH—these mice weighed 95 
slightly less than db/db controls, but showed no improvements in food intake, 96 
body compostion or hyperglycemia (15). The observed decrease in body 97 
weight, with no corresponding change in food intake, led to the hypothesis 98 
that energy expenditure was increased. It is important to note, however, that 99 
this study overexpressed LepR in all SF1 neurons, even those that innately 100 
do no express LepR. To test exactly what contribution native VMH LepR 101 
neurons make to leptin’s control of energy balance, we bred SF1-Cre mice to 102 
LepRloxTB mice, which have a loxP-flanked transcription blocking (TB) 103 
sequence inserted in the LepR gene (2), to produce mice with functional 104 
LepR exclusively in the SF1 neurons of the VMH. We evaluated the role of 105 
leptin signaling specifically in this VMH population in the control of body 106 
weight and composition, food intake, energy expenditure, glucose 107 
homeostasis, and amylin sensitivity. Because loss-of-function studies also 108 
demonstrated that SF1 neurons expressing LepR might mediate sensitivity to 109 
high fat diet (3, 9), we tested if leptin acting on native VMH LepR protects 110 
against DIO in mice challenged with a high fat diet. 111 
  112 
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MATERIAL AND METHODS 113 
Generation of mice with unsilenced leptin receptors in SF1 neurons 114 
To generate mice expressing native LepR exclusively in SF1 cells, LepR Cre-115 
reactivatable mice (LepRloxTB; see (2)) were crossed to mice expressing SF1-116 
Cre. LepRloxTB breeders were purchased from Jackson Laboratory 117 
(Leprtm1Jke; Stock# 018989), and SF1-CreTg/+ mice (9) were provided by Dr. 118 
Joel Elmquist of the University of Texas Southwestern Medical Center, and 119 
maintained by breeding transgenic male mice with C57BL/6J female mice.  120 
Because homozygous LepRloxTB/loxTB mice are reportedly infertile, a three-level 121 
breeding strategy was designed in which the final cross of  LepRloxTB/WT to 122 
LepRloxTB/WT x SF1-Cre Tg/+ generated pups representing all four experimental 123 
conditions within single litters. The four experimental groups generated were: 124 
LepRWT/WT x SF1-Cre WT (WT/WT), expressing normal LepR and no SF1-Cre; 125 
LepRWT/WT x SF1-CreTg/+ (WT/Tg+), expressing normal LepR and SF1-Cre; 126 
LepRloxTB/loxTB x SF1-CreWT (KO/WT), LepR-null, equivalent to db/db mice, and 127 
expressing no SF1-Cre; and LepRloxTB/loxTB x SF1-CreTg/+ (KO/Tg+), LepR-null, 128 
except for the reactivation of native LepR only in SF1-expressing cells of the 129 
VMH.  130 
Mice were genotyped at the age of 6 or 7 days by double transgenic PCR 131 
analysis of toe DNA, which was determined using the following primers 132 
(Microsynth AG), as previously described (1, 12) : TGG CTT TTA AGC TCT 133 
GCA GTC (LepRloxTB common), CTG AGC TGC AGC GCA GGG ACA T (SF1 134 
Cre Tg-F), TGC GAA CCT CAT CAC TCG TTG CAT (SF1 Cre Tg-R), TAG 135 
GGC CAA ACC CAC ATT TA (LepRloxTB WT) and CCC AAG GCC ATA CAA 136 
GTG TT (LepRloxTB KO).  137 
 138 
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Housing and environment 139 
Male and female mice were housed in a temperature-controlled environment 140 
(21 ± 2°C) under a 12/12 hour light-dark cycle. Mice had ad libitum access to 141 
standard chow (Kliba Nafag 3430) and water, except when noted below. A 142 
subgroup of mice was maintained on high fat diet (HFD; 32% kcal from fat, 143 
D12266B from Research Diets) from approximately 5 to 14 weeks of age. 144 
The mice were group housed in macrolon cages until 5 to 6 weeks of age, 145 
when they were single housed in BioDAQ cages to continuously measure 146 
individual food intake. Meal pattern criteria were an inter-meal-interval (IMI) of 147 
600 s and a minimum meal size of 0.02g. Each cage was furnished with a 148 
cardboard house including nest-building material. All experiments were 149 
performed with the approval of the Veterinary Office of the Canton Zurich, 150 
Switzerland, and in accordance with the EU Directive 2010/63/EU on the 151 
protection of animals used for scientific purposes. 152 
 153 
Feeding behavior tests 154 
Between 8 and 12 weeks of age, male and female mice were fasted for 12 155 
hours, and just prior to dark onset treated intraperitoneally (IP) with vehicle or 156 
amylin (20, 100, 1000 μg/kg in 0.9% NaCl; Bachem AG). There were four test 157 
days, each separated by at least 48 hours. On a given test day, each mouse 158 
was randomly assigned to a treatment group, excluding a treatment it had 159 
previously received. By the fourth test day, each mouse had received each 160 
treatment once. At dark onset, the gates of the food hoppers were reopened. 161 
Food intake was automatically measured and analyzed for 22-h post-162 
injection. 163 
 164 
Measurement of baseline energy expenditure 165 
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Following completion of feeding tests, mice were transferred to a 16-cage 166 
TSE PhenoMaster open circuit indirect calorimetry system for the 167 
determination of O2 consumption and CO2 production. Prior to each 168 
experiment, the system was calibrated using certified calibration gases, which 169 
allows the pooling and comparision of data from mulptiple experiments. 170 
Energy expenditure (EE) and respiratory exchange ratio (RER) were 171 
calculated based on equations from Weir (31). To account for differences in 172 
body weight and body mass composition, EE data were corrected for 173 
individual lean body mass (LBM in g) and fat mass (FM in g) using the 174 
following equation: LBM + 0.2FM, as recommended by Even and Nadkarni 175 
(14). 176 
 177 
Intragastric glucose tolerance test (igGTT) and insulin measurement 178 
At the ages of 8 and 12 weeks, basal blood glucose was measured and an 179 
igGTT was performed. Two hours before dark onset, food was removed,  180 
mice were lightly anesthetized under isoflurane, and blood was collected 181 
sublingually in a 100-ul EDTA-coated tube, prepared with a protease inhibitor 182 
(Sigma P2714), and processed for plasma. Plasma insulin and leptin was 183 
measured in duplicate using Mouse/Rat Metabolic assay according to 184 
manufacturer’s protocol (N45ZA-1; Meso Scale Diagnostics). Baseline blood 185 
glucose was measured from whole blood (Glucometer: Breeze2, Bayer). Two 186 
hours later, a second baseline blood glucose was measured from tail blood.  187 
At dark onset, mice were gavaged with 50% glucose solution (2 g/kg), and 188 
blood glucose levels were measured from the tail 15, 30, 45, 60, 90 and 120 189 
minutes later. In mice challenged with HFD, an igGTT was performed at 5 190 
weeks of age, prior to access to HFD, and again at 12 weeks of age, after 7 191 
weeks on HFD. 192 
 193 
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Measurement of body composition 194 
CT scanning was performed using a La Theta LCT-100. The mice were 195 
sutured closed after perfusion, and placed supine in the plexiglass holder. 196 
The X-ray source tube voltage was set at 50kV with 1 mA current.  A sagittal 197 
image of the whole animal was acquired, followed by scans of the entire 198 
animal. The region between the vertebrae L1-L6 was evaluated for lean and 199 
fat mass. 200 
 201 
Perfusion for brain immunohistochemistry 202 
A second cohort of male and female mice was perfused at 8 or 20 weeks of 203 
age to validate the expression of functional LepR in the VMH by assessing 204 
leptin-induced pSTAT3. Mice were fasted for 2 hours, and at dark onset mice 205 
were injected with leptin (3 mg/kg, IP; Peprotech). Mice maintained on HFD 206 
were treated with leptin (5 mg/kg, IP) at 14 weeks old. Forty-five minutes 207 
later, mice were deeply anesthetized with pentobarbital (200 mg/kg IP; 208 
injection volume of 5 ml/kg), and mice were perfused transcardially by 209 
hydrostatic forces with ice-cold potassium phosphate buffered saline (KPBS) 210 
for 2 minutes to flush, and 2% PFA was used to fix the tissue. Brains were 211 
removed and postfixed in 2% PFA for 1 h, and then cryoprotected (20% 212 
sucrose solution in 0.1M PB) overnight at 4°C. Brains were then blocked into 213 
hindbrain and forebrain, flash frozen in hexane on dry ice, and stored at -214 
20°C until sectioning.  215 
 216 
 217 
Immunohistochemistry for pSTAT3 218 
Frozen brains were sectioned through the VMH and ARH at 30 μm on a 219 
cryostat (Leica CM3050S). Coronal brain sections were freeze-thaw mounted 220 
on slides and stored in cryoprotective solution at -20°C until staining.  221 
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Brain sections were incubated with anti-pSTAT3 produced in rabbit (1:1000; 222 
#9145 from Cell Signaling Technology) for 48 hours at 4°C, and then 223 
incubated with Cy3-goat-anti-rabbit (1:200; Jackson Laboratories) for 2 hours 224 
at room temperature. 225 
Quantification of pSTAT3 226 
Sections were imaged at 20x magnification using Zeiss Axioimager Z2 227 
epifluorescence microscope, fitted with Zeiss Axiocam HRm camera, and 228 
AxioVision Imaging System (Carl Zeiss MicroImaging GmbH, Germany). 229 
Images were batch processed using ImageJ and a customized macro. All 230 
images were captured using an exposure time of 270 ms together with linear 231 
image adjustment for the contrast and brightness. For each image, the region 232 
of interest (VMH or ARH) was manually selected, and the macro then 233 
transformed the image into a binary image by subtracting the background and 234 
thresholding the brightness. To separate coalesced cells, the watershed 235 
feature of ImageJ was used. The macro counted pSTAT3-positive cells using 236 
a minimum particle size of 30 pixels. To verify the quantification, an image 237 
overlay identifying each counted cell was generated and saved.  238 
 239 
To assess leptin-induced pSTAT3 across the rostrocaudal extent of the VMH, 240 
we defined and quantified four anatomical levels of VMH and corresponding 241 
levels of ARH; Plate 67, bregma: -1.255 in Allen Mouse Brain Reference 242 
Atlas (10)) was defined as the first level, and the 3 subsequently caudal VMH 243 
sections, separated by steps of 120 μm (bregma levels: -1.375, -1.495, and -244 
1.615), were levels 2 through 4. The average number of pSTAT3-postive cells 245 
across all levels was calculated and compared across groups. Though not 246 
quantified, other hypothalamic nuclei were assessed for the presence of 247 
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leptin-induced pSTAT3 to further verify the specificity of the SF1-targeted 248 
unsilencing. 249 
 250 
Statistical analysis 251 
Data are represented as mean ± SEM. Significance was tested using one-252 
way or two-way ANOVA, followed by Tukey’s multiple comparison, when 253 
appropriate (GraphPad Prism 7 for Mac). When normality was not achieved, 254 
nonparametric Kruskal-Wallis ANOVA was used for comparison. Because the 255 
comparison of KO/WT and KO/Tg+ was most relevant for the interpretation of 256 
our data, posthoc multiple comparisons were primarily made between mice of 257 
the same LepR genotype (i.e. WT/WT vs. WT/Tg+ and KO/WT vs. KO/Tg+). 258 
For the analysis of pSTAT3, igGTT, and amylin data, all groups were 259 
compared with posthoc testing. Total area under the curve (AUC) was 260 
calculated for igGTT data using the trapezoidal rule. A P-value < 0.05 was 261 
considered statistically significant. 262 
 263 
RESULTS  264 
Leptin sensitivity is restored in the VMH of LepRloxTB x SF1-Cre mice  265 
Representative images showing the ARH and VMH of all groups at 8 weeks 266 
of age are shown in Figure 1A-D. At 8-weeks-old, we observed leptin-induced 267 
pSTAT3 in the ARH and VMH of chow-fed WT/WT and WT/Tg+ mice (Fig. 268 
1E). In contrast, pSTAT3 immunoreactivity was completely absent in the ARH 269 
and VMH in KO/WT mice. KO/Tg+ showed a restoration of leptin-induced 270 
pSTAT3 in the VMH, but not the ARH. KO/Tg+ pSTAT3 levels were 271 
significantly higher than KO/WT in the VMH (Fig. 1E). Previous work showed 272 
that not all LepR-expressing neurons in VMH co-express SF1 (9), however, 273 
we found that KO/Tg+ mice had pSTAT3 levels in the VMH comparable to the 274 
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WT groups, with no significant differences between KO/Tg+ and LepR WT 275 
mice in the VMH. To determine if leptin signaling in the VMH diminishes with 276 
age, leptin-induced pSTAT3 was again assessed in 20-week-old chow-fed 277 
mice. At this time point, a pattern of pSTAT3 expression similar to the 8 week 278 
time point was observed in the ARH and VMH (Figs. 1F). In 14-week-old mice 279 
maintained on HFD for 9 weeks, leptin sensitivity was sustained in the ARH 280 
and VMH of WT/WT and WT/Tg+ mice, and in the VMH of KO/Tg+ mice (Fig. 281 
1G). The numbers of pSTAT3-positive cells in the ARH and VMH were similar 282 
to chow-fed mice, however a higher dose of leptin was administered (5 283 
mg/kg) to HFD-fed mice.  284 
 285 
VMH leptin signaling does not ameliorate obesity or increased fat mass 286 
On a normal chow diet (Figs. 2A & B), both male and female KO/WT and 287 
KO/Tg+ mice were significantly heavier than the WT mice from 6 weeks of 288 
age (p<0.001 for all comparisons), but were not significantly different from 289 
each other. When maintained on HFD for 6 weeks (Fig. 2C), we observed an 290 
early and faster body weight gain, which was comparable, in KO/WT and 291 
KO/Tg+ mice. From 6 weeks of age, LepR KO mice were significantly heavier 292 
than WT groups (p<0.001 for all comparisons), but never different from each 293 
other. These effects also did not vary with sex.  294 
 295 
To determine whether restoration of LepR in SF1 neurons affected fat 296 
deposition, we performed CT scans postmortem in 14-week-old mice fed 297 
chow or HFD (Figs. 2D & E). Reactivation of LepR in SF1 neurons was 298 
insufficient to normalize body composition, regardless of maintenance diet. 299 
While lean mass was similar across all groups on both chow and HFD, fat 300 
mass was similarly increased in KO/WT and KO/Tg+ mice.  301 
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 302 
VMH leptin signaling does not normalize energy expenditure or food 303 
intake 304 
We next assessed whether unsilencing of LepR in the VMH protects against 305 
reduced energy expenditure and hyperphagia observed in LepR-deficient 306 
mice. Hourly EE and the average EE for dark and light phases are shown in 307 
Figs. 3A & B. In the dark phase, there was a main effect of the LepR deletion, 308 
with both LepR KO groups expending significantly less energy than LepR WT 309 
groups on chow (F[1, 27] = 5.38, P < 0.05), but KO/WT and KO/Tg+ groups 310 
were not different from each other. No differences across groups were 311 
observed during the light phase. We observed a main effect of LepR on RER 312 
during both dark and light phases (F[1, 27] = 18.96 and 35.72, P < 0.001 for 313 
both; Figs. 3C & D); LepR KO groups exhibited consistently higher RER than 314 
LepR WT, but no differences between KO/WT and KO/Tg+ nor between 315 
WT/WT and WT/Tg+ were found. When maintained on HFD, the LepR-316 
deficiency had a more pronounced lowering effect on EE, which was 317 
significant during both light and dark phases (F[1, 11] = 17.58 and 5.79, P < 318 
0.01 and 0.05; Figs. 3E & F). However, the presence of VMH LepR had no 319 
effect on EE, compared to the KO/WT mice. As anticipated, all groups 320 
showed a reduction in RER when maintained on HFD rather than chow (Figs. 321 
3G & H), with no detectable differences across groups in either phase of the 322 
light cycle.  323 
 324 
Additionally, 24-h chow intake was similarly increased in KO/Tg+ and KO/WT, 325 
compared to LepR WT mice (main effect of LepR, F[1, 26] = 41.43, P < 326 
0.001; Fig. 4A). The increased food intake resulted from an increase in meal 327 
size in KO groups (F[1, 26] = 15.60, P < 0.001; Fig. 4B), while there were no 328 
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differences in meal number across the four genotypes (F[1, 26] = 0.73, P > 329 
0.05; Fig. 4C).  When maintained on HFD, we observed similar differences in 330 
food intake between the obese phenotypes and the control mice, but with no 331 
differences between KO/WT and KO/Tg+ mice; 24-h intake of HFD was 332 
higher in both LepR KO groups (main effect of LepR, F[1, 24] = 22.66, P < 333 
0.001; Fig. 4D), as a function of increased meal size (F[1, 24] = 18.55, P < 334 
0.001; Fig. 4E), with no change in meal number (F[1, 24] = 3.26, P > 0.05; 335 
Fig. 4F).  336 
 337 
VMH leptin signaling mildly improves glucose tolerance in HFD-fed mice 338 
To investigate if VMH leptin signaling contributes to glucose handling, we 339 
performed igGTT on 8-week and 12-week-old mice on chow diet (Figs. 5A & 340 
B). There was no significant difference in fasting glucose (0 min time point) 341 
across the four groups at either age. At 8 weeks, there was an overall effect 342 
of genotype with an impaired glucose tolerance in the LepR KO mice (main 343 
effect of LepR on AUC, F[1, 21] = 8.73, P < 0.01; Fig. 5A inset), however no 344 
differences between KO/WT and KO/Tg+. At 12 weeks, we observed a 345 
stronger overall effect of LepR genotype (main effect of LepR on AUC, F[1, 346 
37] = 96.37, P < 0.001; Fig. 5B inset). Though AUC of KO/WT and KO/Tg+ 347 
were not different at this age, the glucose concentration at 45 min post-348 
gavage was significantly higher in KO/Tg+ than in the KO/WT group (P < 349 
0.01), indicating that VMH leptin signaling worsened the rate of glucose 350 
clearance after the challenge. 351 
 352 
To further examine if VMH leptin signaling changes glucose tolerance under 353 
conditions of DIO, the igGTT was again performed prior to and after 7 weeks 354 
maintenance on HFD (Figs. 5C & D). Prior to HFD, we observed no 355 
differences in baseline blood glucose, and a main effect of LepR genotype on 356 
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AUC (F[1, 24] = 35.39, P < 0.001; Fig. 5C inset), but no difference between 357 
KO/WT and KO/Tg+ mice. Following 7 weeks on HFD (Fig. 5D), however, 358 
KO/WT demonstrated significantly elevated baseline glucose compared to 359 
WT/WT and WT/Tg+ levels (P < 0.05 for both), but not KO/Tg+, and showed 360 
a delay in blood glucose levels returning to baseline, with levels significantly 361 
higher than KO/Tg+ mice at 60 min (P < 0.05). At the 90 (P < 0.001) and 120 362 
min (P < 0.01) time points, only the KO/WT glucose levels were significantly 363 
higher than the mice expressing normal LepR. There was a main effect of 364 
LepR on AUC after HFD (F[1, 24] = 70.33, P < 0.001), but no differences 365 
between KO/WT and KO/Tg+ groups (P = 0.19). These data indicate, that 366 
despite having no effect on obesity or food intake, restoration of LepR in SF1 367 
neurons leads to mildly improved glucose control when mice are maintained 368 
on HFD.   369 
 370 
Baseline plasma insulin and leptin levels were measured in blood samples 371 
collected prior to the igGTT (Figure 5E and F). For all time points and diet 372 
conditions, both KO/WT and KO/Tg+ groups were hyperinsulinemic and 373 
hyperleptinemic compared to LepR-expressing control mice, and in most 374 
cases did not differ from each other. Following HFD consumption for 7 weeks, 375 
however, KO/Tg+ mice were significantly more hyperinsulinemic than KO/WT 376 
mice (P < 0.01). Leptin levels were above the level of detection for two 377 
KO/Tg+ mice and not included in the analysis. 378 
 379 
VMH leptin signaling marginally improves amylin sensitivity 380 
Based on evidence showing that LepR-deficient mice have reduced amylin 381 
sensitivity (11) and that the VMH may mediate leptin and amylin interaction in 382 
rodents (23), we tested whether restored VMH leptin signaling would enhance 383 
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the anorexic response of peripherally administered amylin. The dose-384 
dependent reduction in food intake 1, 2, 4, and 22 h after various doses of 385 
amylin is shown in Figs. 6A-D. In order to directly compare the effectiveness 386 
of amylin to reduce food intake in all genotypes, data were expressed as a 387 
percent of baseline food intake (vehicle treatment = 100%; Figs. 6E-H). One, 388 
2, and 4 hours after amylin treatment, we observed a significant main effect of 389 
amylin (F[3, 162] = 16.07, 8.02, and 13.28, P < 0.001 for each); at 2 hours, 390 
there was a main effect of genotype (F[3, 162] = 3.00, P < 0.05). Post-hoc 391 
analysis showed that after 1 hour, 100 μg/kg of amylin significantly 392 
suppressed food intake in the WT/WT, WT/Tg+ and KO/Tg+ mice (P < 0.05 393 
for all; see Fig. 6E), but not the KO/WT group. The dose of 1000 μg/kg of 394 
amylin suppressed food intake in all groups after 1 hour (WT/WT: P < 0.001; 395 
WT/Tg+ and KO/Tg+: P <0.01; and KO/WT: P < 0.05), but only in the WT/Tg+ 396 
and KO/Tg+ groups after 2 hours (P < 0.05 for both; Fig. 6F). Four hours after 397 
treatment (Fig. 6G), food intake was reduced in the WT/Tg+ after 20 μg/kg of 398 
amylin (P < 0.05), in WT/WT and WT/Tg+ after 100 μg/kg of amylin (P < 0.01 399 
and P < 0.05, respectively), and in all groups after 1000 μg/kg of amylin (P < 400 
0.05 for WT/WT and KO/WT; P < 0.01 for WT/Tg+ and KO/Tg+). 401 402 
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DISCUSSION 403 
The current study aimed to characterize the role of leptin signaling specifically 404 
on VMH neurons in controlling energy and glucose metabolism. To achieve 405 
this, innate LepR expressed only in SF1 neurons were unsilenced in 406 
otherwise LepR-deficient mice. While we could demonstrate that leptin-407 
induced pSTAT3 was present only in the VMH and not other hypothalamic 408 
nuclei, restoration of LepR in SF1 neurons did not prevent the development of 409 
an obese phenotype. VMH leptin signaling did not improve the increased fat 410 
accumulation, increased food intake, reduced energy expenditure, nor 411 
impaired glucose homeostasis, which was observed in a completely LepR-412 
null KO/WT mouse. Furthermore, while leptin action in the VMH is 413 
hypothesized to protect against diet-induced obesity (3), we observed few 414 
benefits of VMH LepR signaling when mice were challenged on HFD. As on 415 
chow, KO/Tg+ remained as obese as KO/WT mice, again demonstrating 416 
increased food intake and reduced energy expenditure. Interestingly, 417 
unsilencing VMH LepR appeared to improve glucose tolerance in mice 418 
maintained on HFD, suggesting that leptin signaling in SF1 neurons could be 419 
relevant for the control of glycemia under pathological conditions, such as 420 
obesity. Overall, our findings definitively demonstrate that leptin signaling in 421 
SF1 neurons of the VMH is not sufficient for the control of energy 422 
homeostasis. 423 
 424 
Earlier reports, which eliminated leptin signaling from SF1 neurons, provided 425 
evidence that LepR expressed in SF1 neurons are necessary controllers of 426 
energy homeostasis. Genetic deletion of LepR from SF1 neurons produced 427 
KO mice that were heavier than WT controls, an effect that was more 428 
pronounced on HFD, and displayed disturbed glucose tolerance (3, 9). When 429 
challenged with HFD, KO mice showed a mild increase in food intake, but a 430 
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clear impairment in the thermogenic response to the HFD. Together, the 431 
published data suggested that deficiency in LepR in SF1 neurons leads to 432 
increased susceptibility to DIO, which results from impaired control of food 433 
intake and energy expenditure (3, 9).  434 
 435 
Because of these findings, we hypothesized that re-activation of native LepR 436 
in SF1 neurons would promote metabolic health and protect against obesity, 437 
but this is not what we observed. A previous study investigated the result of 438 
overexpression of LepR in all SF1-expressing neurons, and observed a 439 
slightly leaner phenotype than db/db mice, with no correction of diabetes or 440 
elevated glucagon levels (15). Unlike our model, in which only natively-441 
expressed LepR were unsilenced from SF1 neurons, this model produced an 442 
overexpression of LepR in all SF1 neurons, resulting in a heightened leptin-443 
induced pSTAT3 in the VMH (15).  Because leptin does not seem to uniformly 444 
activate or inhibit SF1 neurons (25), the net output of these overexpressed 445 
LepR and how it relates to the net output of the native population was not 446 
entirely clear. Results from the overexpression study, showing reduced 447 
obesity with no change in food intake, led to the hypothesis that LepR 448 
signaling in SF1 neurons increases energy expenditure (15). Our results, 449 
however, do not confirm this hypothesis.  450 
 451 
While it is possible that LepR expressed on SF1 neurons truly are not critical 452 
mediators of metabolic state, we propose two potential explanations for our 453 
primarily null findings. First, leptin signaling in the VMH is complex, and it is 454 
possible that unsilencing innate LepR in the SF1 neurons may not restore all 455 
functions of these neurons or this nucleus in its entirety. It is known that up to 456 
20% of leptin-activated neurons in the VMH are negative for SF1 (9), and 457 
because our model should not reactivate expression of LepR in non-SF1 458 
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neurons, we can only speculate how these discrete populations interact or 459 
influence downstream behavioral or physiological output. In a recent report, 460 
Meek and colleagues hypothesized that this non-SF1 LepR population may 461 
influence the net output of SF1/LepR neurons (22), an idea which is further 462 
complicated by the fact that the VMH contains SF1 neurons that are both 463 
depolarized and hyperpolarized by leptin (25). Future investigations into the 464 
microcircuitry of SF1 LepR neurons and the role of non-SF1 neurons 465 
expressing the LepR within in the VMH are necessary to understand why 466 
selective reactivation of native LepR on SF1 neurons in the VMH has little 467 
consequence on the obese phenotype of LepR-null mice. 468 
 469 
A second interpretation is that this population of LepR cannot function in 470 
isolation, nor can it compensate for the severe metabolic disturbance 471 
produced by the absence of all other LepR populations.  It is possible that 472 
leptin signaling via SF1 neurons requires additional populations of functional 473 
LepR, such as in the ARH or non-SF1 neurons in the VMH, in order to induce 474 
changes in metabolism. It is established that postnatal ARH leptin signaling is 475 
required for correct organization of hypothalamic circuitry (5). Leptin-deficient 476 
ob/ob mice and LepR-deficient db/db mice show disturbed neuronal 477 
projections from the ARH to the paraventricular nucleus of the hypothalamus, 478 
which is a critical pathway in the control of energy balance (4). This 479 
phenotype is presumably replicated in our KO/WT and KO/Tg+ mice, which 480 
lack ARH LepR. As the ARH is a known target of VMH projections (26), and a 481 
potentially critical mediator of the VMH’s effects on energy balance, it is 482 
possible that disturbed ARH circuitry halts downstream transmission of the 483 
leptin signal generated in the VMH of KO/Tg+ mice. A more direct relationship 484 
between ARH and VMH LepR signaling might also exist; co-activation of 485 
these ARH POMC neurons by leptin could be necessary to transduce the 486 
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hypothesized anorexic action that follows SF1 leptin signaling. Interestingly, 487 
reactivation of LepR exclusively in POMC neurons also did not correct the 488 
hyperphagia observed in LepR-null mice, and only modestly corrected obesity 489 
(2), which would support the hypothesis that both LepR populations are 490 
required for leptin’s full effect on food intake and body weight control.  491 
 492 
KO/Tg+ mice showed a slight improvement in glucose tolerance compared to 493 
the KO/WT mice, but only when they were maintained on HFD. Because the 494 
KO/Tg+ and KO/WT mice on HFD did not differ in body weight or food intake, 495 
it is possible that restoration of LepR in the VMH directly influenced insulin 496 
signaling in the VMH to alter glucose metabolism. It was previously shown 497 
that LepR-deficient db/db mice have reduced insulin-induced pAkt in ARH 498 
neurons, corroborating that functional leptin signaling is important for insulin 499 
signal transduction (18). Interestingly, activity of insulin-responsive SF1 500 
neurons was shown to also vary with diet (17). These neurons are overactive 501 
specifically under conditions of HFD-feeding and concomitant 502 
hyperinsulinemia, two conditions present in our KO/Tg+ mice, which results in 503 
elevated PI3K activation and a proposed inhibition of the glutamatergic VMH 504 
projections to ARH POMC neurons (17). While VMH insulin signaling should 505 
not theoretically be disrupted in any of our experimental groups, it is possible 506 
that the effect on glucose tolerance we observed in the KO/Tg+ mice results 507 
from an interaction between the HFD-induced hyperactivity in insulin-508 
responsive SF1 neurons and enhanced pAkt signaling in these neurons, 509 
which could be a secondary result of unsilencing of VMH LepR.  510 
 511 
Because obesity-induced leptin resistance is a major hurdle in developing 512 
leptin-based therapies to combat obesity, the pancreatic hormone amylin 513 
received significant attention for its capacity to restore leptin sensitivity in 514 
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obese humans and rats (23, 24, 29). It was proposed that amylin and leptin 515 
synergize by activating complementary, but discrete, neuronal signaling 516 
pathways, and that the VMH is a critical locus of convergence for these 517 
pathways (23, 30). While much of this research has focused on how amylin 518 
sensitizes leptin, our recent findings showed that LepR-deficient mice (db/db) 519 
and rats (ZDF) have reduced amylin-induced satiation, and that db/db mice 520 
also exhibit reduced amylin-induced Fos in the primary target nucleus of 521 
amylin, the area postrema (AP; 11), suggesting a bi-directional dependency 522 
of these hormones. We were therefore interested in knowing if restoring LepR 523 
function in a specific neuronal population could restore amylin sensitivity, and 524 
hypothesized that reactivation of LepR in SF1 neurons would enhance amylin 525 
signaling in LepR-deficient rodents. Similar to the db/db mice in the previous 526 
study (11), the KO/WT mice exhibited an altered dose-response to amylin; 527 
notably, the 100 μg/kg dose failed to reduce food intake in these mice. In 528 
contrast, by restoring VMH LepR signaling, the KO/Tg+ group exhibited a 529 
dose-response to amylin more similar to the LepR WT groups, with the 100 530 
μg/kg dose of amylin reducing food intake. Whether this effect is 531 
physiologically significant will require further investigation. Interstingly, while 532 
only statistically significant in the LepR WT groups, all groups demonstrated 533 
reduced food intake at the 4-hour time point. Because amylin in the blood has 534 
a very short half life of less than 15 min (32), it is known that the “fast” or 535 
direct action of amylin is quite short, and its effect on food intake begins to 536 
dissipate 2 hours after administration. This revived reduction in food intake at 537 
4 hours, most notable in the KO/WT group which showed little suppression 538 
prior to this time point, suggests the presence of a “slow” action of amylin, 539 
one which could be independent of leptin action. 540 
 541 
PERSPECTIVES AND SIGNIFICANCE 542 
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We observed that LepR signaling specifically in SF1 neurons of the VMH is 543 
not sufficient to mediate the metabolic effects of leptin in animals that are 544 
otherwise LepR deficient. VMH LepR signaling, however, improved glucose 545 
homeostasis under HFD conditions. These findings suggest that SF1 neurons 546 
in the VMH might contribute to the regulation of leptin-mediated glucose 547 
homeostasis following diet-induced obesity. The presence of SF1 LepR also 548 
enhanced responsiveness to acute amylin treatment. Further studies should 549 
address whether leptin signaling in the VMH plays a subordinate role in 550 
metabolic regulation or if its functions depend on connections with other 551 
leptin-regulated nuclei in the brain.   552 
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FIGURE LEGENDS 686 
 687 
Figure 1. LepR are only unsilenced in the VMH of KO/Tg+ mice. 688 
Representative fluorescent photomicrographs of leptin-induced (3 mg/kg) 689 
pSTAT3 immunoreactivity in 8-week-old WT/WT (A), WT/Tg+ (B), KO/WT 690 
(C), KO/Tg+ (D) mice fed with chow. Mean ± SEM number of pSTAT3 691 
positive cells across four anatomical levels of ARH and VMH in 8-week-old 692 
(E) and 20-week-old (F) male and female chow-fed mice. N = 5-6 mice/group. 693 
Mean ± SEM number of pSTAT3 positive cells across four anatomical levels 694 
of ARH and VMH in 14-week-old male and female mice fed with HFD for 9 695 
weeks (G). N = 4-7 mice/group. Scale bar = 150 μm. Fluorescent images 696 
were inverted to improve visibility. Symbols denote significant differences 697 
between KO/WT vs. KO/Tg+; *P<0.05, **P<0.01 as determined using 698 
Kruskal-Wallis ANOVA followed by Dunn’s multiple comparison test. 699 
 700 
Figure 2. Unsilencing of LepR in SF1 VMH neurons has no effect on 701 
body weight or composition. Mean ± SEM weekly body weight of male (A; 702 
N = 8-10 mice/group), and female (B; N = 5-6 mice/group) mice on chow diet, 703 
and male and female mice on high fat diet (C; N = 5-8 mice/group). Mean ± 704 
SEM mass of lean, visceral fat, and subcutaneous fat as measured by CT 705 
scan in 14-week-old male and female mice maintained on chow (D; N = 7-9 706 
mice/group) or HFD (E; N = 5-8 mice/group). D and E also depict the 707 
correction factor used to normalize energy expenditure data, which was 708 
calculated using lean body mass (LBM) + 0.2 fat mass (FM). The region 709 
between the vertebrae L1-L6 was evaluated for lean and fat mass. 710 
Comparisons of body weight and composition were made using two-way 711 
ANOVA followed by Tukey’s multiple comparison. 712 
 713 
Figure 3. Selective reactivation of LepR in SF1 VMH neurons does not 714 
improve energy expenditure (EE) or respiratory exchange ratio (RER). 715 
Mean ± SEM energy expenditure (A, B, E, F) and respiratory exchange ratio 716 
(C, D, G, H) calculated hourly (A, C, E, G) and during dark and light phase (B, 717 
D, F, H) measured in WT/WT (N = 9), WT/Tg+ (N = 7), KO/WT (N = 6), and 718 
KO/Tg+ (N = 9) male and female mice fed standard chow (A-D) or WT/WT (N 719 
= 4), WT/Tg+ (N = 3), KO/WT (N = 4), and KO/Tg+ (N = 4) male and female 720 
mice fed high fat diet (E-H). Symbols denote significant main effects of the 721 
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LepR: *P<0.05, **P<0.01, ***P<0.001 as determined using two-way ANOVA 722 
followed by Tukey’s multiple comparison. 723 
 724 
Figure 4. Selective reactivation of LepR in SF1 VMH neurons does not 725 
reduce food intake or alter meal patterns. Mean ± SEM 24-hour food 726 
intake (A, D), meal size (B, E) and meal number (C, F) measured in WT/WT, 727 
WT/Tg+, KO/WT, and KO/Tg+ male and female mice fed standard chow (A-728 
C; N = 5-10 mice/group) or high fat diet (D-F; N = 5-8 mice/group). 729 




Figure 5. VMH leptin signaling mildly improves glucose tolerance in 734 
HFD-fed mice. Mean ± SEM blood glucose concentrations measured during 735 
intragastric glucose tolerance test (igGTT) in WT/WT, WT/Tg+, KO/WT, and 736 
KO/Tg+ male and female mice fed chow diet at 8 weeks (A; N = 3-9 737 
mice/group) and 12 weeks of age (B; N = 9-12 mice/group). igGTT was 738 
repeated in a second cohort of mice at 5 weeks of age (C; N = 5-8 739 
mice/group), and age at 12 weeks (D; N = 5-8 mice/group) after 6 weeks on 740 
HFD. Insets show mean ± SEM AUC for glucose levels during the 120-min 741 
test. Prior to glucose gavage, plasma insulin (E) and leptin (F) were 742 
measured in male and female mice maintained on chow (N = 7-10 743 
mice/group)  or HFD for 6 weeks (N = 3-8 mice/group). Symbols denote 744 
significant differences between KO/WT and KO/Tg+: *P<0.05, **P<0.01, or 745 
significant differences between KO/WT and WT/WT and WT/Tg+: P<0.01, 746 
P<0.001 as determined using two-way ANOVA followed by Tukey’s 747 
multiple comparison. 748 
 749 
 750 
Figure 6. VMH leptin signaling marginally improves amylin sensitivity. 751 
Mean ± SEM cumulative food intake in WT/WT (N = 15), WT/Tg+ (N = 12), 752 
KO/WT (N = 10) and KO/Tg+ (N = 9) male and female mice at one (A), two 753 
(B), four (C) and twenty-two hour (D) after treatment with vehicle, 20, 100 or 754 
1000 μg/kg amylin (IP). Food intake data represented as a percentage of 755 
vehicle baselines in WT/WT, WT/Tg+, KO/WT and KO/Tg+ are shown in E-H. 756 
Symbols denote significant differences from vehicle treatment: WT/WT 757 
*P<0.05, **P<0.01, ***P<0.001; WT/Tg+ P<0.05, P<0.01; KO/WT 758 
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 28 
§P<0.05; KO/Tg+ ^P<0.05, ^^P<0.01 as determined using two-way ANOVA 759 
followed by Tukey’s multiple comparison. 760 
 761 
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